Mitsubishi UFJ Asset Management Co. Ltd. Trims Stock Position in Astera Labs, Inc. $ALAB

Mitsubishi UFJ Asset Management Co. Ltd. trimmed its holdings in Astera Labs, Inc. (NASDAQ:ALAB) by 32.5% during the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The fund owned 73,944 shares of the company’s stock after selling 35,632 shares during the period. Mitsubishi UFJ Asset Management Co. Ltd.’s holdings in Astera Labs were worth $14,478,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Clearstead Advisors LLC lifted its holdings in shares of Astera Labs by 13.6% during the 3rd quarter. Clearstead Advisors LLC now owns 636 shares of the company’s stock worth $125,000 after acquiring an additional 76 shares during the period. Great Valley Advisor Group Inc. increased its position in Astera Labs by 2.2% during the second quarter. Great Valley Advisor Group Inc. now owns 4,119 shares of the company’s stock worth $372,000 after purchasing an additional 90 shares during the last quarter. Rye Brook Capital LLC increased its position in Astera Labs by 1.1% during the third quarter. Rye Brook Capital LLC now owns 9,200 shares of the company’s stock worth $1,801,000 after purchasing an additional 100 shares during the last quarter. Assetmark Inc. raised its stake in Astera Labs by 374.1% during the third quarter. Assetmark Inc. now owns 128 shares of the company’s stock worth $25,000 after purchasing an additional 101 shares during the period. Finally, First Horizon Advisors Inc. boosted its holdings in shares of Astera Labs by 12.4% in the 2nd quarter. First Horizon Advisors Inc. now owns 982 shares of the company’s stock valued at $89,000 after purchasing an additional 108 shares during the last quarter. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

Astera Labs stock opened at $120.55 on Tuesday. Astera Labs, Inc. has a 12-month low of $47.13 and a 12-month high of $262.90. The company has a market capitalization of $20.52 billion, a price-to-earnings ratio of 98.81, a price-to-earnings-growth ratio of 2.34 and a beta of 1.75. The firm’s fifty day moving average price is $157.14 and its 200 day moving average price is $171.82.

Astera Labs (NASDAQ:ALAB) last announced its earnings results on Tuesday, February 10th. The company reported $0.58 earnings per share for the quarter, beating the consensus estimate of $0.51 by $0.07. Astera Labs had a return on equity of 16.12% and a net margin of 25.70%.The company had revenue of $270.58 million during the quarter, compared to the consensus estimate of $249.46 million. During the same period last year, the firm earned $0.37 earnings per share. The company’s revenue was up 91.8% on a year-over-year basis. Astera Labs has set its Q1 2026 guidance at 0.530-0.540 EPS. Analysts forecast that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Insider Activity at Astera Labs

In other Astera Labs news, COO Sanjay Gajendra sold 94,971 shares of the stock in a transaction on Tuesday, February 17th. The shares were sold at an average price of $123.81, for a total transaction of $11,758,359.51. Following the transaction, the chief operating officer directly owned 1,531,301 shares in the company, valued at $189,590,376.81. This represents a 5.84% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this link. Also, CFO Michael Truett Tate sold 12,001 shares of the business’s stock in a transaction dated Tuesday, February 17th. The stock was sold at an average price of $123.81, for a total transaction of $1,485,843.81. Following the completion of the sale, the chief financial officer directly owned 192,083 shares of the company’s stock, valued at $23,781,796.23. The trade was a 5.88% decrease in their position. The SEC filing for this sale provides additional information. Over the last three months, insiders sold 206,792 shares of company stock valued at $25,602,869. Insiders own 12.50% of the company’s stock.

Analyst Ratings Changes

A number of analysts have recently commented on ALAB shares. Roth Mkm upped their price objective on Astera Labs from $200.00 to $225.00 and gave the stock a “buy” rating in a report on Wednesday, November 5th. Royal Bank Of Canada started coverage on Astera Labs in a research note on Wednesday, January 14th. They set an “outperform” rating and a $225.00 price target for the company. Raymond James Financial assumed coverage on Astera Labs in a report on Friday, November 21st. They issued a “hold” rating on the stock. Morgan Stanley reiterated an “overweight” rating and set a $210.00 target price on shares of Astera Labs in a report on Wednesday, December 3rd. Finally, Northland Securities raised their price target on shares of Astera Labs from $175.00 to $195.00 and gave the company an “outperform” rating in a report on Tuesday, December 9th. Fourteen investment analysts have rated the stock with a Buy rating, six have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $192.89.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.